Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia

• Miguel Carracedo, PhD,
• Leif Stenke, MD, PhD,
• Anders Franco-Cereceda, MD, PhD,
• Magnus Bäck, MD, PhD

Affiliations

Miguel Carracedo, PhD

Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Leif Stenke, MD, PhD

Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Division of Hematology, Karolinska University Hospital, Stockholm, Sweden

Anders Franco-Cereceda, MD, PhD

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Theme Heart and Vessels, Division of Valvular and Coronary Disease, Karolinska University Hospital, Stockholm, Sweden

Magnus Bäck, MD, PhD

Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Division of Hematology, Karolinska University Hospital, Stockholm, Sweden; Address for correspondence: Dr. Magnus Bäck, Karolinska University Hospital, Theme Heart and Vessels, Division of Valvular and Coronary Disease, M85, 141 86 Stockholm, Sweden.